{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-220557","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.098637+00:00","generated_at":"2026-06-23T23:44:09.081760+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Halozyme proposes $500M convertible notes due 2028, plans $200M share repurchase and debt repayment","bullets":["$500M aggregate principal of convertible senior notes due 2028; initial purchasers have option for additional $75M.","Proceeds uses: up to $200M share repurchases (increase of $100M vs prior 2022 plan), exchange of existing 1.25% convertibles, and repayment of $250M term loan due 2026.","Capped call transactions will be entered to reduce potential dilution upon conversion of the notes.","Interest rate and conversion rate determined at pricing; conversions settled in cash plus stock if applicable."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-220557","json":"https://secwatch.observer/filing/0001193125-22-220557.json","markdown":"https://secwatch.observer/filing/0001193125-22-220557.md","text":"https://secwatch.observer/filing/0001193125-22-220557.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000119312522220557/0001193125-22-220557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000119312522220557/d295619d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:44:09.081760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}